Tag: Slate
Skadden advises Otsuka on potential USD1.2bn biotech buy
Skadden, Arps, Slate, Meagher & Flom is advising Tokyo-based Otsuka Pharmaceutical on its acquisition of clinical-stage biotechnology company
Deals of the Year 2025
A look back at the blockbuster transactions of 2025 as we gallop into the Year of the Horse




















